Everolimus for subependymal giant cell astrocytoma: 5-year final analysis

Everolimus for the treatment of lymphangioleiomyomatosis: a phase II study

(2015) Hilary J. Goldberg et al.   EUROPEAN RESPIRATORY JOURNAL

Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study

(2014) David Neal Franz et al.   LANCET ONCOLOGY

The effects of everolimus on tuberous sclerosis-associated lesions can be dramatic but may be impermanent

(2014) Joseph M. Miller et al.   PEDIATRIC NEPHROLOGY

Everolimus long-term safety and efficacy in subependymal giant cell astrocytoma

(2013) D. A. Krueger et al.   NEUROLOGY

Tuberous Sclerosis Complex Surveillance and Management: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference

(2013) Darcy A. Krueger et al.   PEDIATRIC NEUROLOGY

Surgical Treatment of Subependymal Giant Cell Astrocytoma in Tuberous Sclerosis Complex Patients

(2013) Katarzyna Kotulska et al.   PEDIATRIC NEUROLOGY

Outcomes of resecting subependymal giant cell astrocytoma (SEGA) among patients with SEGA-related tuberous sclerosis complex: a national claims database analysis

(2012) Peter Sun et al.   CURRENT MEDICAL RESEARCH AND OPINION

Everolimus: preventing organ rejection in adult kidney transplant recipients

(2012) Jacques Dantal   EXPERT OPINION ON PHARMACOTHERAPY

Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial

(2012) David Neal Franz et al.   LANCET

Everolimus alters white matter diffusion in tuberous sclerosis complex

(2012) J.-M. Tillema et al.   NEUROLOGY

Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial

(2011) Klemens Budde et al.   LANCET

Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis

(2011) Francis X. McCormack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Everolimus in Clinical Practice in Long-Term Liver Transplantation: An Observational Study

(2011) T. Casanovas et al.   TRANSPLANTATION PROCEEDINGS

Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis

(2010) Darcy A. Krueger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Diffusion Features of White Matter in Tuberous Sclerosis With Tractography

(2010) Michelle L. Krishnan et al.   PEDIATRIC NEUROLOGY

Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature

(2009) M. E. A. P. M. Adriaensen et al.   EUROPEAN JOURNAL OF NEUROLOGY

New Equations to Estimate GFR in Children with CKD

(2009) G. J. Schwartz et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

The TSC1–TSC2 complex: a molecular switchboard controlling cell growth

(2008) Jingxiang Huang et al.   BIOCHEMICAL JOURNAL

The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis

(2008) G.F.L. Hofbauer et al.   BRITISH JOURNAL OF DERMATOLOGY

Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis

(2008) John J. Bissler et al.   NEW ENGLAND JOURNAL OF MEDICINE

The pathogenesis and imaging of the tuberous sclerosis complex

(2008) Henry J. Baskin   PEDIATRIC RADIOLOGY